[Clinical basis of provocative detoxicating etiotropic therapy of chronic toxoplasmosis in pediatric cases].
Clinical and laboratory data on the treatment of 19 children with chronic toxoplasmosis were used for estimation of the efficacy of drug combination, such as spiramycin + lidase and lincomycin + lidase vs. the traditional therapy (co-trimoxazole, metronidazole). The combination designed by us, i.e. spiramycin + lidase, lincomycin + lidase used in consecutive courses proved to be more efficient.
Kulmagambetov
I P
IP
Timofeev
I V
IV
Begaĭdarova
R Kh
RKh
Konstantinidi
T A
TA
Perevertova
E S
ES
D000284:Administration, Oral; D002648:Child; D002908:Chronic Disease; D003049:Coccidiostats / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000008:administration & dosage / Q000627:therapeutic use*; D007273:Injections, Intramuscular; D008034:Lincomycin / Q000008:administration & dosage / Q000627:therapeutic use*; D015572:Spiramycin / Q000008:administration & dosage / Q000627:therapeutic use*; D014123:Toxoplasmosis / Q000188:drug therapy*
D003049:Coccidiostats; D015572:Spiramycin; D008034:Lincomycin; C001543:lidase; D006821:Hyaluronoglucosaminidase